Advisor Group’s Asensus Surgical, Inc. ASXC Stock Holding History

Advisor Group’s Portfolio ASXC Stock Details ASXC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	$19K	Buy	13,373 +1,017	+8%	+$3.53K	﹤0.01%	4004
2019 Q3	$99K	Buy	12,356 +2,585	+26%	+$35.1K	﹤0.01%	2891
2019 Q2	$173K	Buy	9,771 +29	+0.3%	+$635	﹤0.01%	2425
2019 Q1	$301K	Buy	9,742 +856	+10%	+$28.7K	﹤0.01%	1969
2018 Q4	$262K	Buy	8,886 +105	+1%	+$4.77K	﹤0.01%	1892
2018 Q3	$663K	Sell	8,781 -1,058	-11%	-$71.6K	0.01%	1267
2018 Q2	$558K	Sell	9,839 -504	-5%	-$18.4K	0.01%	1224
2018 Q1	$228K	Sell	10,343 -217	-2%	-$4.96K	﹤0.01%	1874
2017 Q4	$265K	Buy	10,560 +1,050	+11%	+$32.3K	﹤0.01%	1777
2017 Q3	$177K	Buy	9,510 +1,142	+14%	+$13.3K	﹤0.01%	1944
2017 Q2	$77K	Buy	8,368 +2,063	+33%	+$19.6K	﹤0.01%	2520
2017 Q1	$99K	Sell	6,305 -423	-6%	-$7.33K	﹤0.01%	2161
2016 Q4	$114K	Sell	6,728 -11,900	-64%	-$244K	﹤0.01%	1982
2016 Q3	$409K	Sell	18,628 -393	-2%	-$7.18K	0.01%	1087
2016 Q2	$301K	Buy	+19,021	New	+$597K	0.01%	1203

Other funds holding ASXC

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

SHI

SV Health Investors Boston, Massachusetts $32.3M AUM 20.15% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

MCM

Masters Capital Management Atlanta, Georgia $3.03B AUM 57.21% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Advisor Group's ASXC Position: Q4 2019 in Review

Advisor Group increased its Asensus Surgical, Inc. (ASXC) stake by 8.2% in Q4 2019, buying an estimated $3.53K and bringing the position to 13,373 shares worth $19K. The position accounts for ﹤0.01% of the portfolio, ranked #4004.

Advisor Group first reported a position in ASXC in Q2 2016 and has held it in 15 quarters since. The position peaked at $663K in Q3 2018. 81 funds tracked by Wall St. Rank hold ASXC as of Q4 2019.

Advisor Group held 13,373 shares of Asensus Surgical, Inc. worth $19K as of Q4 2019.
Advisor Group bought 1,017 Asensus Surgical, Inc. shares in Q4 2019, an estimated $3.53K.
Asensus Surgical, Inc. made up ﹤0.01% of Advisor Group's portfolio in Q4 2019, its #4004 holding.
Advisor Group first reported a position in Asensus Surgical, Inc. in Q2 2016 and has held it in 15 quarters since.
Advisor Group's Asensus Surgical, Inc. position peaked at $663K in Q3 2018.
81 funds tracked by Wall St. Rank held Asensus Surgical, Inc. as of Q4 2019.

Based on Advisor Group's 13F filing for Q4 2019, filed 12 Feb 2020.